Literature DB >> 15843403

Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors.

Claire L Navarro1, Juan Cadiñanos, Annachiara De Sandre-Giovannoli, Rafaëlle Bernard, Sébastien Courrier, Irène Boccaccio, Amandine Boyer, Wim J Kleijer, Anja Wagner, Fabienne Giuliano, Frits A Beemer, Jose M Freije, Pierre Cau, Raoul C M Hennekam, Carlos López-Otín, Catherine Badens, Nicolas Lévy.   

Abstract

Restrictive dermopathy (RD) is characterized by intrauterine growth retardation, tight and rigid skin with prominent superficial vessels, bone mineralization defects, dysplastic clavicles, arthrogryposis and early neonatal death. In two patients affected with RD, we recently reported two different heterozygous splicing mutations in the LMNA gene, leading to the production and accumulation of truncated Prelamin A. In other patients, a single nucleotide insertion was identified in ZMPSTE24. This variation is located in a homopolymeric repeat of thymines and introduces a premature termination codon. ZMPSTE24 encodes an endoprotease essential for the post-translational cleavage of the Lamin A precursor and the production of mature Lamin A. However, the autosomal recessive inheritance of RD suggested that a further molecular defect was present either in the second ZMPSTE24 allele or in another gene involved in Lamin A processing. Here, we report new findings in RD linked to ZMPSTE24 mutations. Ten RD patients were analyzed including seven from a previous series and three novel patients. All were found to be either homozygous or compound heterozygous for ZMPSTE24 mutations. We report three novel 'null' mutations as well as the recurrent thymine insertion. In all cases, we find a complete absence of both ZMPSTE24 and mature Lamin A associated with Prelamin A accumulation. Thus, RD is either a primary or a secondary laminopathy, caused by dominant de novo LMNA mutations or, more frequently, recessive null ZMPSTE24 mutations, most of which lie in a mutation hotspot within exon 9. The accumulation of truncated or normal length Prelamin A is, therefore, a shared pathophysiological feature in recessive and dominant RD. These findings have an important impact on our knowledge of the pathophysiology in Progeria and related disorders and will help direct the development of therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843403     DOI: 10.1093/hmg/ddi159

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  104 in total

Review 1.  Protein farnesylation and disease.

Authors:  Giuseppe Novelli; Maria Rosaria D'Apice
Journal:  J Inherit Metab Dis       Date:  2012-02-04       Impact factor: 4.982

2.  Prelamin A processing and functional effects in restrictive dermopathy.

Authors:  Marta Columbaro; Elisabetta Mattioli; Elisa Schena; Cristina Capanni; Vittoria Cenni; Nicolas Levy; Claire L Navarro; Rosalba Del Coco; Stefano Squarzoni; Daria Camozzi; Chris J Hutchison; Manfred Wehnert; Giovanna Lattanzi
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

Review 3.  Inner nuclear membrane proteins: impact on human disease.

Authors:  Iván Méndez-López; Howard J Worman
Journal:  Chromosoma       Date:  2012-02-04       Impact factor: 4.316

Review 4.  A-type lamin complexes and regenerative potential: a step towards understanding laminopathic diseases?

Authors:  Josef Gotzmann; Roland Foisner
Journal:  Histochem Cell Biol       Date:  2005-09-02       Impact factor: 4.304

Review 5.  Laminopathies: multiple disorders arising from defects in nuclear architecture.

Authors:  Veena K Parnaik; Kaliyaperumal Manju
Journal:  J Biosci       Date:  2006-09       Impact factor: 1.826

6.  HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells.

Authors:  Catherine Coffinier; Sarah E Hudon; Emily A Farber; Sandy Y Chang; Christine A Hrycyna; Stephen G Young; Loren G Fong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-25       Impact factor: 11.205

Review 7.  Mouse models of the laminopathies.

Authors:  Colin L Stewart; Serguei Kozlov; Loren G Fong; Stephen G Young
Journal:  Exp Cell Res       Date:  2007-03-31       Impact factor: 3.905

Review 8.  Adult stem cell maintenance and tissue regeneration in the ageing context: the role for A-type lamins as intrinsic modulators of ageing in adult stem cells and their niches.

Authors:  Vanja Pekovic; Christopher J Hutchison
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

9.  Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis.

Authors:  Yue-Bei Luo; Chalermchai Mitrpant; Russell Johnsen; Vicki Fabian; Merrilee Needham; Sue Fletcher; Steve D Wilton; Frank L Mastaglia
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

Review 10.  When lamins go bad: nuclear structure and disease.

Authors:  Katherine H Schreiber; Brian K Kennedy
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.